Biglari, S.; Mischak, H.; Beige, J.; Latosinska, A.; Siwy, J.; Banasik, M.
The Future of Chronic Kidney Disease Treatment: Combination Therapy (Polypill) or Biomarker-Guided Personalized Intervention? Biomolecules 2025, 15, 809.
https://doi.org/10.3390/biom15060809
AMA Style
Biglari S, Mischak H, Beige J, Latosinska A, Siwy J, Banasik M.
The Future of Chronic Kidney Disease Treatment: Combination Therapy (Polypill) or Biomarker-Guided Personalized Intervention? Biomolecules. 2025; 15(6):809.
https://doi.org/10.3390/biom15060809
Chicago/Turabian Style
Biglari, Sajjad, Harald Mischak, Joachim Beige, Agnieszka Latosinska, Justyna Siwy, and Mirosław Banasik.
2025. "The Future of Chronic Kidney Disease Treatment: Combination Therapy (Polypill) or Biomarker-Guided Personalized Intervention?" Biomolecules 15, no. 6: 809.
https://doi.org/10.3390/biom15060809
APA Style
Biglari, S., Mischak, H., Beige, J., Latosinska, A., Siwy, J., & Banasik, M.
(2025). The Future of Chronic Kidney Disease Treatment: Combination Therapy (Polypill) or Biomarker-Guided Personalized Intervention? Biomolecules, 15(6), 809.
https://doi.org/10.3390/biom15060809